Skip to main content

Peer Review reports

From: HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial

Original Submission
26 May 2023 Submitted Original manuscript
22 Aug 2023 Reviewed Reviewer Report - Cheney Drew
17 Oct 2023 Reviewed Reviewer Report - Shriya Das
19 Oct 2023 Reviewed Reviewer Report - Yuya Dou
30 Oct 2023 Reviewed Reviewer Report - Qiuxia Cui
16 Nov 2023 Author responded Author comments - Budhi Singh Yadav
Resubmission - Version 2
16 Nov 2023 Submitted Manuscript version 2
19 Nov 2023 Reviewed Reviewer Report - Shriya Das
28 Nov 2023 Reviewed Reviewer Report - Cheney Drew
6 Dec 2023 Reviewed Reviewer Report - Qiuxia Cui
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
6 Dec 2023 Editorially accepted
2 Jan 2024 Article published 10.1186/s13063-023-07851-7

You can find further information about peer review here.

Back to article page